SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dr. Voodoo who wrote (2088)1/27/1998 9:09:00 PM
From: Dauntless  Read Replies (3) of 7041
 
Just a thought -

Perhaps the reason most of the papers you're finding are by Imhof is he was at Ciba-Geigy & in that time period - say 1970 - 1981 - the patent was still valid & they were the only manufacturer - hence no one else cared. Later, when it came off patent, it had already been replaced by better drugs for its original indication as a vasodilator?

Wish I add more - maybe I'll poke around & get back to you.

BTW, you wrote:

>>Blood levels are an accepted measurement, and a cornerstone for Asensio and Zonagen to make their assertions. My guess originally was that both sides would have data to back up their claims, so far this has been true.<<

Where is Asensio's data proving his assertion? The study he quoted used an UNVALIDATED technique. Those results would NEVER be accepted
by any trained analytical chemist. The claims made by Asensio in the Jan. 15th report are completely untrue. He reported them for their shock value in a continuing attempt to manipulate the share price.

While we argue back & forth here, he gets big time publicity for his lies on PRNewswire & Businesswire. Of course, it works both ways & creates wonderful buying opportunities for knowledgeable investors.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext